Real-time enrollment status for this triple negative breast cancer clinical trial
Current Status
Active, Not Recruiting
Checked: June 1, 2026 at 10:43 PM UTC
| NCT Number | NCT03971409 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Triple Negative Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 150 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Laura Huppert, MD, BA |
| Last Updated on CT.gov | April 17, 2026 (Apr 17, 2026) |
As of June 1, 2026: Clinical trial NCT03971409 is currently active_not_recruiting participants. This clinical trial study for triple negative breast cancer is not currently accepting new participants at 12 locations across the United States. The study is sponsored by Laura Huppert, MD, BA. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT03971409 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03971409 was last updated Apr 17, 2026 (April 17, 2026). HelloStudys verifies this status automatically.